Advertisement
Advertisement
MOLN
Molecular Partners AG - ADR
4.05
USDSponsored
0.00
0.00%
Aug 07, 15:55 UTC -4
Closed
Pre-Market
4.11
+0.06
+1.48%
MOLN Earnings Reports
Positive Surprise Ratio
MOLN beat 4 of 4 last estimates.
100%
Next Report
Date of Next Report
Aug 25, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
--
/--
Molecular Partners AG - ADR earnings per share and revenue
On --, MOLN reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q2 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ANI Pharmaceuticals, Inc.
Report Date
Aug 07, 2026 For Q2 26
Estimate
$2.09
Actual
$2.21
Surprise
+5.69%
REGENXBIO Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.05
Actual
$0.43
Surprise
+626.35%
X4 Pharmaceuticals, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.18
Actual
-$0.13
Surprise
+29.19%
SAB Biotherapeutics, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.29
Actual
-$0.28
Surprise
+5.15%
Cellectis S.A. - ADR
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.27
Actual
-$0.22
Surprise
+20.89%
Entera Bio Ltd. Ordinary Shares
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.14
Surprise
-71.57%
Genmab A/S ADS
Report Date
Aug 06, 2026 For Q2 26
Estimate
$3.59
Actual
$0.54
Surprise
-84.98%
Praxis Precision Medicines, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$3.73
Actual
-$2.87
Surprise
+23.14%
Halozyme Therapeutics, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.87
Actual
$2.27
Surprise
+21.75%
Cytokinetics Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$1.67
Actual
-$1.50
Surprise
+10.35%
FAQ
What were Molecular Partners AG - ADR's earnings and revenue for the latest quarter Q-- --?
For Q-- --, Molecular Partners AG - ADR reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
How did the market react to Molecular Partners AG - ADR's Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Molecular Partners AG - ADR expected to report next?
The next earning report is scheduled for Aug 25, 2026.
What are the forecasts for Molecular Partners AG - ADR's next earnings report?
Based on --
analysts, Molecular Partners AG - ADR is expected to report EPS of -- and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement